COMMUNIQUÉS West-GlobeNewswire

Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection
14/05/2018
RANCHO CUCAMONGA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the U.S. Food and Drug Administration (“FDA”) granted approval of the company’s abbreviated new [...]
International Endeavors Corporation, a Medical Marijuana IP Holdings Company, Secures a $500,000 Investment Commitment From Voltage River
14/05/2018
TEMECULA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation, a Medical Marijuana IP Holdings Company, today announces that the Company has received an investment commitment of [...]
Invitation: Terveystalo result audiocast and conference call on 16 May 2018
14/05/2018
Terveystalo Plc will publish its Interim report for January-March 2018 on 16 May 2018 at approximately 9:00 a.m. EEST (Finnish time). The company will hold an audiocast and conference call in English at 12:30 EEST ( [...]
Xbrane Biopharma and Episurf invites to a company presentation in Stockholm May 29
14/05/2018
Press release 2018-05-14 Xbrane Biopharma and Episurf Medical invites to a company presentation held at Episurf Medical's office at Karlavägen 60 in Stockholm on May 29, 18.00-20.30 CEST. Xbrane Biopharma will be [...]
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
14/05/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period Paris, France and [...]
mise à jour: Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise
14/05/2018
Il sagit dune mise à jour du communiqué 08:00 14.05.2018 CEST. Explication de la mise à jour; mauvais logo. Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Ablynx annoncent le succès des [...]
Xbrane Biopharma releases interim report for the first quarter of 2018
14/05/2018
Press release 2018-05-14 Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for the first quarter of 2018 is now available on the Company's website, www.xbrane.com . Financial summary first quarter 201 8 Revenues [...]
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
14/05/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period Paris, France and [...]
Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise
14/05/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Ablynx annoncent le succès des offres publiques d'acquisition sur Ablynx et le lancement d'offres de reprise Paris, France et Gand, Belgique - [...]
SANOFI AND ABLYNX ANNOUNCE THE SUCCESSFUL RESULTS OF THE INITIAL TENDER OFFER PERIOD FOR ABLYNX AND COMMENCEMENT OF SQUEEZE-OUT TENDER PERIOD
14/05/2018
Paris, France and Ghent, Belgium - May 14, 2018 - Sanofi [Euronext: SAN; NYSE: SNY] and Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced the results of the initial tender offer period of Sanofi's previously [...]
Vistin Pharma ASA : Commencement of subscription period for the subsequent repair issue
14/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy
14/05/2018
LYON, France, May 14, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq: ERYP ), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances [...]
PledPharma has completed the recruitment for the clinical trial with Aladote®
14/05/2018
Stockholm, May 14, 2018. PledPharma AB (publ) has fully recruited all patients in the proof-of-principle study with the drug candidate Aladote ® (PP100-01 for Overdose of Paracetamol Trial, “POP”). Aladote ® is being [...]
Fagron NV: Disclosure of received notification
14/05/2018
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 14 May 2018 Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received the [...]
Radius Health to Present at the Bank of America Merrill Lynch 2018 Annual Healthcare Conference
12/05/2018
WALTHAM, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that Jesper Høiland, President and Chief Executive officer and Pepe Carmona, Senior Vice President and Chief Financial [...]
Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
12/05/2018
New approval for Gilenya (fingolimod) addresses strong unmet need for younger patients, who often experience more frequent relapses than adults with multiple sclerosis (MS)[1] In a landmark controlled Phase III study of [...]
New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony
11/05/2018
Late-Breaking Presentation at Heart Rhythm 2018 Shows Potential for More Patients to Benefit from World's Smallest Pacemaker DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE: MDT ) today announced new clinical [...]
Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy
11/05/2018
Late-Breaking Presentation at Heart Rhythm 2018 Highlights Investigational Experience with ICD Lead Placed Under Sternum, Outside the Heart and Veins DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE: MDT ) today [...]
Evelo Biosciences Announces Closing of Initial Public Offering
11/05/2018
CAMBRIDGE, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO ) (“Evelo”) today announced the closing of its initial public offering of 5,312,500 shares of common stock at a public offering [...]

Pages